Enhanced response of leukemia (L1210) mice to combination chemotherapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) and 5-fluorouracil (NSC-19893).
D000818:Animals; D001391:Azo Compounds / Q000008:administration & dosage; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004357:Drug Synergism; D005472:Fluorouracil / Q000008:administration & dosage*; D007093:Imidazoles / Q000008:administration & dosage*; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009711:Nucleotides / Q000096:biosynthesis; D011687:Purines / Q000096:biosynthesis
D001391:Azo Compounds; D004273:DNA, Neoplasm; D007093:Imidazoles; D009711:Nucleotides; D011687:Purines; D005472:Fluorouracil